Price as of close on Nov 3, 2026 · Financials updated Oct 6, 2026
Basics
Sector
Basic Materials
Industry
Specialty Chemicals
Country
United States
Market cap
3.7B USD
Enterprise value
4.9B USD
Full-time employees
4,064
Overall health
Strength:its shares are priced lower than most peers relative to what it earnspriced lower than peers for its earnings
Drawback:growing more slowly than most peersgrowing more slowly than peers
Drawback:higher risk than most peers: more debt relative to equity (0.79× vs a peer median of 0.36×)higher risk: more debt vs equity (0.79× vs peers 0.36×)
Ranks #655 of 1,217 basic materials companies (bottom 47%)
Operating margin at a 6-year high.17% in FY Sep 2025, the best of the last 6 years.
Cabot kept 17% of revenue as operating profit in FY Sep 2025, its highest in the 6 years of filings we have.
Investment surge. Capital spending 7.4% of revenue, up from 4.9% in FY Sep 2022.
Cabot is spending 7.4% of revenue on facilities and equipment, up from 4.9% in FY Sep 2022. That weighs on free cash flow today; whether it pays off depends on the returns those investments earn.
Share count shrinking. Shares outstanding down 8.2% from September 2022 to July 2026.
Cabot had 8.2% fewer shares at July 2026 than at September 2022, mainly through buybacks, so each remaining share owns a larger slice of the business.
Profitable, but revenue is shrinking. More profitable than most peers, but revenue fell 4.7% in the 12 months to June 2026 vs the 12 months before.
Cabot is more profitable than most peers, yet revenue fell 4.7% in the 12 months to June 2026 vs the 12 months before.
Valuation, growth and profitability scores: higher is better. Risk: 0 is lower, 2 is higher. Risk is a relative proxy, not a bankruptcy probability. Scores depend on available sector peers.
Questions investors ask about Cabot
Is Cabot getting weaker?
Its latest SEC filing (Aug 4, 2026) got weaker in some ways: operating margin fell 2.2 points to 13.6%. Its overall score is unchanged at 49/100 since Oct 28, 2026.
How is Cabot valued vs its peers?
Priced lower than most peers relative to what it earns. Valuation scores 76/100 against 1,371 basic materials peers.EBITDA yield 14.2% vs a peer median of 8.5% (stronger than 77% of peers).EBITDA yield 14.2% vs peers 8.5% (stronger than 77% of peers).
Is Cabot growing?
More slowly than most of its peers. Growth scores 19/100 against 1,371 basic materials peers.Earnings per share growth -53.9% vs a peer median of 9.4% (weaker than 91% of peers).Earnings per share growth -53.9% vs peers 9.4% (weaker than 91% of peers).
How profitable is Cabot?
More profitable than most of its peers. Profitability scores 73/100 against 1,371 basic materials peers.Return on invested capital 14.8% vs a peer median of 6.7% (stronger than 77% of peers).Return on invested capital 14.8% vs peers 6.7% (stronger than 77% of peers).
How risky is Cabot?
Higher risk relative to 1,371 basic materials peers, judged on debt, liquidity and share-price swings.Debt / equity 0.79× vs a peer median of 0.36× (weaker than 76% of peers).Debt / equity 0.79× vs peers 0.36× (weaker than 76% of peers). A relative measure, not a bankruptcy probability.
Latest filing: what changed
Quarter ended Jun 30, 2026 · filed Aug 4, 2026 · compared with the quarter ended Mar 31, 2026
Got weaker
Operating margin fell 2.2 points to 13.6%
Previous quarter
Latest quarter
Change
Revenue (12 months)
3.6B USD
3.6B USD
+1.7%
Net income (12 months)
285.0M USD
190.0M USD
−33.3%
Operating margin
15.7%
13.6%
−2.2 pts
Free cash flow (12 months)
432.0M USD
281.0M USD
−35.0%
Debt
1.3B USD
1.3B USD
−2.0%
Cash
252.0M USD
250.0M USD
−0.8%
Shares outstanding
51.6M
51.6M
+0.0%
From the company’s own SEC filings, as filed. Twelve-month figures roll forward one quarter at a time.
Industry valuation context
Industry: Specialty Chemicals · 32 companies
Valuations in Specialty Chemicals are above their usual range since 2016.
74% of months since 2016 were valued lower than now.
17% of companies are in the most expensive fifth of their own price-to-sales history.
Over 24 months, company values −8% and earnings +13% (medians): earnings grew faster than prices.
Median price-to-sales is −36% vs the whole market, against a usual −31%.
2016Shaded: most expensive fifth of its range2026
This is a cyclical group: after a downturn, trailing earnings and sales fall faster than prices, which can make valuations look high near a cycle's low.
Describes valuations since 2016; it does not predict prices. US companies worth $1B+, from SEC filings and month-end prices, as of Aug 2026. Today's companies and industry labels are used throughout. Measured on earnings, EBITDA, sales and free cash flow yields. How this works
Financials
Fiscal years from SEC annual filings · change vs the prior year
Key ratios
FY Sep 2021
FY Sep 2022
FY Sep 2023
FY Sep 2024
FY Sep 2025
Change
Gross margin
23.4%
20.5%
21.3%
24.0%
25.3%
▲ 1.3 pts
Operating margin
13.3%
9.0%
13.4%
15.4%
16.7%
▲ 1.4 pts
Net margin
7.3%
4.8%
11.3%
9.5%
8.9%
▼ 0.6 pts
Return on assets (ROA)
7.6%
5.9%
12.3%
10.2%
8.7%
▼ 1.5 pts
Return on equity (ROE)
26.4%
23.3%
35.2%
26.7%
21.4%
▼ 5.3 pts
Free cash flow margin
1.8%
-2.6%
8.9%
11.3%
10.5%
▼ 0.8 pts
Current ratio
1.24×
1.65×
1.98×
2.08×
1.61×
▼ 23%
Quick ratio
0.79×
1.05×
1.27×
1.36×
1.08×
▼ 21%
Debt to equity
1.23×
1.61×
1.01×
0.80×
0.73×
▼ 8.9%
Interest coverage
9.27×
6.95×
5.84×
7.58×
8.17×
▲ 7.8%
CBT price history
Price history is added with the daily price update and will appear after the next one.